The most recent investment milestone for faCellitate was a €3.70MSeed Round investment announced on 07 September 2022. Remarkably, this investment was led by a consortium of prominent investors, including Arve Capital, Chemovator, SARSTEDT, R3, HTGF | High-Tech Gruenderfonds, and ROI land investment. With this substantial funding, faCellitate is positioned to further advance its offerings and solidify its presence in the biotechnology sector. To learn more about faCellitate and its groundbreaking products, visit their website at https://facellitate.com.
faCellitate
We provide interactive consumables for advanced cell technologies to create biologically relevant environments.
Founded 2019
Mannheim, Germany
13 employees
Seed
Total: $3.70M
Biotechnology
Mannheim, Germany
13 employees
Seed
Total: $3.70M
Biotechnology
General Information
Company Name
faCellitate
Founded Year
2019
Location
Mannheim, Germany
Mannheim, Germany
Employees
13
Industries
Biotechnology
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with faCellitate. To contact faCellitate, visit facellitate.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does faCellitate compare?
A PDF of faCellitate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting faCellitate soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Germany Market
Biotechnology
About faCellitate
Business keywords: Advanced cell technologies, Regenerative medicine, Surface coatings, Cell culture, Biologically relevant environments, Multicellular spheroids, Organoids, BIOFLOAT™ products, Interactive consumables, High-performance inert coating, 3D culture, Lab ware, Biomedical engineering
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | €3.70M | 6 |
|
07 Sep 2022 |
faCellitate Alternatives & Competitors
faCellitate vs
Matrigen
United States
Introducing Softwell®. It's coming to a lab near you.
2 employees
Biotechnology, Health Care
faCellitate vs
faCellitate vs
Pioneering breakthroughs in regenerative medicine with advanced cell-based and tissue-engineered sol...
Series C
Biotechnology, Pharmaceutical
FAQ About faCellitate
We provide interactive consumables for advanced cell technologies to create biologically relevant environments.
faCellitate was founded in 2019.
faCellitate is headquartered in Mannheim, Germany.
faCellitate operates in Biotechnology. Its work centres on Advanced cell technologies, Regenerative medicine, Surface coatings and Cell culture.
faCellitate has approximately 13 employees.
faCellitate has completed 1 funding round, raising a total of $3.70M. The latest funding stage is Seed.
Top alternatives and competitors to faCellitate include Matrigen, Akron Bio, Advanced BioHealing, China Regenerative Medicine International, Vericel® Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
faCellitate and Matrigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for faCellitate, https://bouncewatch.com/company/facellitate, updated 30 December 2024. When citing, please name BounceWatch and link this page.
